Value of granulocyte colony stimulating factor in radiotherapy induced neutropenia: Clinical and laboratory studies
- 31 December 1995
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (3) , 302-307
- https://doi.org/10.1016/0959-8049(94)00488-q
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The effect of GM-CSF and G-CSF on the growth of human osteosarcoma cellsin vitro andin vivoInternational Journal of Cancer, 1994
- Granulocyte colony-stimulating factor treatment of leucopenia during fractionated radiotherapyEuropean Journal Of Cancer, 1993
- Use of recombinant granulocyte-colony stimulating factor to treat neutropenia occurring during craniospinal irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1993
- The use of G-CSF during craniospinal irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Bladder Cancer Cells Express Functional Receptors for Granulocyte-Colony Stimulating FactorJournal of Urology, 1992
- British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease – long term resultsBritish Journal of Cancer, 1991
- Various human hematopoietic growth factors (interleukin-3, GM-CSF, G- CSF) stimulate clonal growth of nonhematopoietic tumor cells [see comments]Blood, 1989
- Contribution of immunohistochemistry to diagnostic problems of human cerebral tumors.Journal of Histochemistry & Cytochemistry, 1978
- A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's diseaseBritish Journal of Cancer, 1977
- Screening of Cytotoxic Drugs for Residual Bone Marrow Damage 2JNCI Journal of the National Cancer Institute, 1976